The Nepal authorities has not formally responded to the Chinese choice yet. Though the Nepal government granted approval for emergency use of the vaccine developed by China's Sinopharm on February 18, the lack of correct documentation of its trial outcomes and logistic issues has prevented its rollout for larger public
